Home Authors Posts by Marina Temkin

Marina Temkin

Coronavirus Bounceback
LPs’ fears of large markdowns in VC assets did not materialize. Valuations through Q2 are expected to either stay relatively flat or even increase, especially for late-stage focused managers.
Boston-based HLM Venture Partners has an extensive history in the sector and is currently raising its fifth $125m fund.
The Silicon Valley veteran talks about his investment in Rigetti and why he says there is a lot of excitement regarding the nascent field of quantum computing.
LP Brijesh Jeevarathnam Adams Street
In 2016, the LP formed a dedicated early-stage venture capital fund by leveraging its existing VC program. It continues to re-up with long-term partners as it also adds one or two new GPs a year.
Growth Strategy
The private markets advisory firm believes the pandemic has created even greater investment opportunities in the late-stage and growth equity sectors.
Biotech
Appetite for biopharma is on the rise as investors want to back scientific advances and the recession-proof sector, and generalist VCs don’t want to miss out on potential outsized returns.
The online provider of personal healthcare will likely not be doing a reverse merger with a SPAC soon, according to a venture source.
VC investment in biopharma and health tech continues to soar amid the covid-19 pandemic.
VC Kyle Lui, DCM Ventures
The venture capitalist discusses PPP loans, where Lime is experiencing growth and a company that has not survived the downturn.
Oregon LP makes one of its largest VC commitments in history to Sherpa Venture Capital's debut effort, investing half of the fund target.
vcj
vcj

Copyright PEI Media

Not for publication, email or dissemination